Gluckman E, Devergie A, Faille A, Barrett A J, Bonneau M, Boiron M, Bernard J
Nouv Presse Med. 1978 Feb 11;7(6):439-43.
The etiology of aplastic anemia is unknown. A stem cell lesion caused by a toxic or a virus or a microenvironment defect are the main hypothesis. An auto-immune origin has been recently suspected but never proved. To demonstrate the auto-immune origin of the disease. We have treated 17 patients with severe aplastic anemia with antilymphocyte serum (ALS). Nine patients showed no improvement and seven patients died within two months of infectious or hemorrhagic complications. In contrast, eight patients had a prompt rise of granulocytes and reticulocytes counts. Although the hematological reconstitution is not complete. This eight patients are still alive between 4 months and 15 months after treatment. This study shows that A.L.G. may have a beneficial effect in the treatment of patients with severe aplastic anemia.
再生障碍性贫血的病因尚不清楚。由毒素、病毒或微环境缺陷引起的干细胞损伤是主要假说。最近怀疑有自身免疫起源,但从未得到证实。为了证明该疾病的自身免疫起源,我们用抗淋巴细胞血清(ALS)治疗了17例重型再生障碍性贫血患者。9例患者无改善,7例患者在两个月内死于感染或出血并发症。相比之下,8例患者的粒细胞和网织红细胞计数迅速上升。虽然血液学重建不完全,但这8例患者在治疗后4个月至15个月仍存活。本研究表明,抗淋巴细胞球蛋白(ALG)可能对重型再生障碍性贫血患者的治疗有有益作用。